Celastrol as an emerging anticancer agent: Current status, challenges and therapeutic strategies
2023 · Biomedicine & Pharmacotherapy · 115 citations
https://doi.org/10.1016/j.biopha.2023.114882
K
Ke Fu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
49
Papers
1.8K
Citations
21
h-index
30
i10-index
Ke Fu is an academic researcher from Zhejiang A & F University. The author has contributed to research in topics: Liver Disease Diagnosis and Treatment & Liver physiology and pathology & Drug-Induced Hepatotoxicity and Protection. The author has an h-index of 21, co-authored 42 publications.
ORCID: 0000-0003-4511-424XPapers by this author
worksCD44‐Targeting Drug Delivery System of Exosomes Loading Forsythiaside A Combats Liver Fibrosis via Regulating NLRP3‐Mediated Pyroptosis
2023 · Advanced Healthcare Materials · 75 citations
https://doi.org/10.1002/adhm.202202228
Phillygenin inhibited M1 macrophage polarization and reduced hepatic stellate cell activation by inhibiting macrophage exosomal miR-125b-5p
2023 · Biomedicine & Pharmacotherapy · 51 citations
https://doi.org/10.1016/j.biopha.2023.114264
Advances in Chemical Constituents, Clinical Applications, Pharmacology, Pharmacokinetics and Toxicology of Erigeron breviscapus
2021 · Frontiers in Pharmacology · 44 citations
https://doi.org/10.3389/fphar.2021.656335
Mesenchymal stem cell-derived exosomes and non-coding RNAs: Regulatory and therapeutic role in liver diseases
2022 · Biomedicine & Pharmacotherapy · 27 citations
https://doi.org/10.1016/j.biopha.2022.114040
Exploring the effect and mechanism of cucurbitacin B on cholestatic liver injury based on network pharmacology and experimental verification
2023 · Journal of Ethnopharmacology · 21 citations
https://doi.org/10.1016/j.jep.2023.117584
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat